statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Unveiling 4 Analyst Insights On Genelux

Why Genelux Corporation (GNLX) Shares Are Down 40%

Genelux shares are trading lower by 40.7% during Friday's session. The company announced the pricing of an underwritten offering of 6.875 million shares.
read more...

Brokers Set Expectations for Genelux Co.'s FY2028 Earnings (NASDAQ:GNLX)

Genelux Co. (NASDAQ:GNLX - Free Report) - Research analysts at HC Wainwright issued their FY2028 EPS estimates for shares of Genelux in a research report issued to clients and investors on...

Genelux (NASDAQ:GNLX) Price Target Lowered to $32.00 at HC Wainwright

Genelux (NASDAQ:GNLX - Free Report) had its price objective reduced by HC Wainwright from $35.00 to $32.00 in a research report sent to investors on Tuesday, Benzinga reports. They currently have a...

GNLX Stock Earnings: Genelux Misses EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips
GNLX stock results show that Genelux missed analyst estimates for earnings per share the fourth quarter of 2023.
The post GNLX Stock...

Genelux reports Q4 EPS (25c), consensus (19c)

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Genelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Continued active enrollment of Olvi-Vec in our pivotal Phase 3 OnPrime/GOG-3076 trial in platinum resistant/refractory ovarian cancer with topline results anticipated in 2H 2025 Initiation of...

LifeSteps Financial Inc. Purchases 2,191 Shares of Genelux Co. (NASDAQ:GNLX)

LifeSteps Financial Inc. boosted its position in Genelux Co. (NASDAQ:GNLX - Free Report) by 6.7% during the fourth quarter, according to the company in its most recent filing with the Securities...

12 titres de soins de sant  en mouvement lors de la session apr s-cl ture le 08/03/2024

Gagnants
L'action Genelux (NASDAQ:GNLX) a mont vendredi de 10,06% 7 dollars lors de la session after-market.
L'action Telesis Bio (NASDAQ:TBIO) a mont de 9,28% 0,60 dollars.
Le titre Estrella...

12 titoli sanitari in movimento, after-market del 08/03/2024

Titoli in rialzo
Le azioni di Genelux (NASDAQ:GNLX) hanno fatto segnare +10,06% a 7 dollari durante la sessione after-market di venerd .
Il titolo Telesis Bio (NASDAQ:TBIO) ha avuto un aumento del...

Genelux Corp. manufactures and markets drugs and virus strains solutions. It provides drug research, development, and clinical trial services for the healthcare industry. The company was founded by Aladar Szalay in 2001 and is headquartered in Westlake Village, CA.

Volume	151,793.00
52-Wk High	$30.44
52-Wk Low	$1.71

GNLX Genelux Corp

About

Feed

News

Earnings

Fundamentals